Menu
← Oncology Approval Tracker
FDA DECISION ·
Methotrexate Injection (Accord)
methotrexate · Accord Healthcare
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
The methotrexate injection label expanded its non-Hodgkin lymphoma indication to include pediatric patients. The supplement also revised dosing for ALL and NHL.
LAMPGEN ANALYSIS
Why it matters
The revision consolidates Burkitt lymphoma within NHL and extends the labeled lymphoma population to children.
What research teams should watch
Update pediatric protocol references and verify indication-specific dosing, route and rescue requirements.
PRIMARY RECORDS